Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
11/2008
11/20/2008WO2008139079A2 Method for the co-production of cyclic carbonates and amino acids
11/20/2008WO2008138639A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008US20080287694 Processes for producing a fluorosulfonyl group-containing compound and a compound led from the fluorosulfonyl group-containing compound
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080283384 Process for Producing Trioxane and at Least One Comonomer
11/20/2008DE102008000275A1 Alkenacetale und ihre Verwendung als Riechstoffe Alkenacetale and their use as odorants
11/20/2008CA2686484A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/19/2008EP1992606A1 Alkene acetals and their use as odorous substances
11/19/2008EP1680413B1 NEW RAR-beta RECEPTOR-ACTIVATING LIGAND, METHOD FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/18/2008US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing
11/18/2008US7452999 Chemical process for the preparation of intermediates to obtain N-formyl hydroxy-lamine compounds
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/06/2008WO2008132474A1 Synthesis of cyclic carbonates in the presence of dimeric aluminium (salen) catalysts
11/06/2008US20080275100 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080274927 5-isopropenyl-4,8-dimethylbicyclo[3.3.1]non-7-en-2-one; 5-isopropenyl-4,8-dimethylbicyclo[3.3.1]non-7-en-2-ol; 4,8-dimethyl-5-isopropenylspiro[bicyclo[3.3.1]nonane-2,2'-[1,3]dioxolane]; incorporating to a base odourant molecules such as essential oils, alcohols etc. perfume, cosmetics, laundry product
11/06/2008US20080272052 Contacting perselective membrane; creating a pressure differential; cyclic formals formed from dialcohol and formaldehyde
11/05/2008EP1988072A1 Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
11/05/2008EP1987018A1 Process for the production of alkylene carbonate and use of alkylene carbonate thus produced in the manufacture of an alkane diol and a dialkyl carbonate
11/05/2008EP1306362B1 Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
11/05/2008CN100430345C Method for producing compounds having CF2O bridge
10/2008
10/30/2008WO2008128956A1 Process for preparing an 1,2-alkylene carbonate
10/30/2008WO2008074693A3 Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
10/30/2008US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
10/29/2008CN101293885A New purpose of acid doped conductive polyaniline
10/28/2008US7442814 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
10/28/2008US7442813 Process for producing dioxolane nucleoside analogues
10/28/2008US7442809 Method for producing 1,3-dioxolan-4,6-dione compound
10/28/2008US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
10/28/2008US7442718 Inhibitors of aspartyl protease
10/28/2008US7442702 Prostaglandin agonists
10/23/2008WO2008124878A1 Non-steroidal compounds
10/23/2008WO2008064827A3 Process for preparing nebivolol
10/23/2008US20080262230 Tachykinin receptor anatgonist; good transfer into blood; long half-life; stability; bradycardial agents; antiinflammatory agents ; antallergens; analgesics; antiemetics; irritable bowel disorders; skin disorders; antidepressants; antiischemic agents ; anxiolytic agents; autoimmune diseases; muscle relax
10/22/2008EP1983009A1 Method for producing the fluorinated compounds and polymers
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291668A Atr inhibitor
10/22/2008CN100427477C Process of synthesizing cyclic carbonate by epoxy compound with carbon dioxide reaction
10/21/2008US7439379 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
10/21/2008US7439378 Coordination catalyst
10/16/2008WO2008122620A1 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerisation
10/16/2008US20080255376 Method For the Production of Dioxolane
10/16/2008US20080255373 Process for the production of glycerol carbonate esters
10/16/2008US20080255372 Process for Preparing Glyceryl Carbonate
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255095 Benzylamine analogues
10/15/2008EP1979308A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
10/15/2008EP1978959A2 Piperidine and piperazine derivatives
10/15/2008EP1308436B1 Calcium receptor antagonists
10/15/2008CN101287720A Process for preparing glyceryl carbonate
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008009926A3 Safrole replacements
10/08/2008CN101282958A Method for the production of dioxolane
10/08/2008CN101282933A Novel NK1 and NK2 antagonists
10/08/2008CN101280042A Polymer loaded with ion liquid, preparation and application thereof
10/08/2008CN101279968A Storing method of vinylene carbonate
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/02/2008US20080242721 Glycerol Levulinate Ketals and Their Use
10/01/2008EP1975153A2 Protease inhibitors
10/01/2008EP1974732A1 Therapeutic agent for neurodegenerative disease
10/01/2008EP1973404A1 Malononitrile compounds
09/2008
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008CA2473596C Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
09/25/2008US20080234501 Reacting xylene with chloroacetyl chloride forming 2-chloro-1-(2,5-dimethylphenyl)ethanone; rearrangement; hydrolysis
09/25/2008US20080234481 Forming salts such as tartrate or mandelate ; chemical intermediate
09/25/2008US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties
09/25/2008US20080234152 Alkyl Acetal Compound, Process for Producing the Same, and Lubricating Oil Composition
09/24/2008CN101270114A Lignanoids compounds, preparation method and application thereof
09/24/2008CN101270113A Preparation of multi-chiral catalyst, preparation and application of cyclic carbonates with optical activity
09/24/2008CN101270112A Preparation of polymerization type chiral catalyst, preparation and application of cyclic carbonates with optical activity
09/24/2008CN100420685C Process for preparing vinylidene carbonate
09/24/2008CN100420684C Alkyl glycidol carbonates used as co-surfactants
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/23/2008CA2355749C 4-methylene-1,3-dioxolanes as cross-linking agents
09/18/2008WO2008111414A1 Catalyst composition, and process for production of cross-coupling compound using the same
09/18/2008WO2008111282A1 Method for producing carbonyl compound
09/18/2008WO2008110278A2 Use of n2-phenylamidines as herbicides and herbicidal agents comprising the same
09/18/2008CA2680617A1 Use of n2-phenylamidines as herbicides
09/17/2008EP1970368A1 Method for producing olefin compound
09/17/2008EP1970119A1 Catalytic composition for the insertion of carbon dioxide into organic compounds
09/17/2008EP1968975A2 Tylophorine analogs as antitumor agents
09/17/2008CN101265253A Multi-phase catalysis synthesis method for cyclic carbonates
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425631 Compounds and methods of use
09/16/2008CA2188872C Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
09/12/2008WO2008108429A1 Method of retaining the quality of 2-methyl-3-(3,4-methylenedioxyphenyl)propanal and process for producing the same
09/11/2008US20080221207 Use of specific cyklolignans
09/11/2008US20080221206 less anesthetic activity, but with more anti-inflammatory and spasmolytic activity; asthma, rhinitis, allergic urticaria, chronic lung inflammation associated with eosinophilia, following the example of atopic asthma and chronic intestinal inflammation, as colitis for instance
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 183